论文部分内容阅读
目的探讨甘精胰岛素联合门冬胰岛素治疗2型糖尿病围手术期的有效性及安全性。方法选择46例需择期手术的2型糖尿病患者随机分为两组,分别为甘精胰岛素联合门冬胰岛素组(G+A组)和胰岛素泵治疗组(CSⅡ组),观察两组患者血糖控制水平、血糖达标时间、低血糖发生率、术前准备时间、平均住院日等指标。结果 G+A组与CSⅡ组在血糖控制情况、血糖达标时间、低血糖发生率、术前准备时间、平均住院日各项指标比较差异无统计学意义。结论甘精胰岛素联合门冬胰岛素在2型糖尿病围手术期是安全,有效,迅速,方便的治疗方法。
Objective To investigate the efficacy and safety of insulin glargine plus insulin aspart in the perioperative period of type 2 diabetes mellitus. Methods Forty-six patients with type 2 diabetes who underwent elective surgery were randomly divided into two groups: insulin glargine combined with insulin aspart (G + A group) and insulin pump treatment group (CSⅡ). The blood glucose control Level, blood glucose compliance time, the incidence of hypoglycemia, preoperative preparation time, the average length of stay and other indicators. Results There was no significant difference between the G + A group and the CS Ⅱ group in the control of blood glucose, the time of reaching the blood glucose level, the incidence of hypoglycemia, preoperative preparation time and average length of stay. Conclusion Glargine and insulin aspart in the perioperative period of type 2 diabetes is a safe, effective, rapid and convenient treatment.